Please ensure Javascript is enabled for purposes of website accessibility

Why Flora Growth Shares Shot Nearly 7% Higher on Friday

By Eric Volkman – Sep 17, 2021 at 5:27PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's all about a momentous event that happened recently in a small Central American country.

What happened

The stock of Canadian marijuana company Flora Growth (FLGC 2.39%) produced a sweet high for investors at the end of the week by closing Friday almost 7% higher. That was on the back of the company's announcement that it has signed a deal to enter a new market in Latin America.

So what

Flora Growth isn't wasting any time jumping into what is almost certain to become the world's newest medical marijuana market, Panama. The cannabis company announced that it has signed a letter of intent with that country's Robust Farms covering the import of Flora Growth's cannabidiol-derivative products.

The Canadian company did not disclose any financial particulars of the arrangement. 

Marijuana leaf with sun shining behind it.

Image source: Getty Images.

Panama is a hot topic in the cannabis world these days. On Aug. 30, its legislature, the National Assembly, unanimously passed a bill legalizing the consumption and sale of medical marijuana. The bill is still awaiting the signature of President Laurentino Cortizo, but given the lopsided vote and the support of the general populace for the move, it's likely this will occur fairly soon.

The company already has operations in Colombia, one of the very few Latin American countries that has legalized medical marijuana so far.

Now what

Flora Growth is clearly anticipating more dominoes will fall in the region. In the likely case that occurs, we can count on the company making early pushes into those markets just like it's doing with Panama.

It quoted CEO Luis Merchan as saying, "It's important to recognize the continued trend of medical and adult-use cannabis legalization sweeping across the globe as governments increasingly recognize its therapeutic properties, and want to control, regulate, and tax these products to foster economic prosperity, as well as bring significant reform in civil rights and criminal justice."

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.